A Single Arm Phase 4 Trial to Evaluate the Safety and Efficacy of Oral Fruquintinib in the Treatment of Refractory Metastatic Colorectal Cancer in Patients from Minority Populations Underrepresented in Prior Fruquintinib Studies

15889TAK-113-4002OpenA Single Arm Phase 4 Trial to Evaluate the Safety and Efficacy of Oral Fruquintinib in the Treatment of Refractory Metastatic Colorectal Cancer in Patients from Minority Populations Underrepresented in Prior Fruquintinib StudiesNCT06562543IndustrialAdultTreatmentIVNationalColonNoel, MarcusMedStar Health and GUMC; Medstar Washington Hospital Center : Nour Abu IrhayemGastrointestinalOncology GroupMHRI Washington Cancer Institute16800Nour Abu IrhayemNour Abu Irhayemnour.b.abuirhayem@medstar.net2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>